documents: FDA-2021-N-0862-0140

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-N-0862-0140 FDA FDA-2021-N-0862 Nonprescription Drug Product With an Additional Condition for Nonprescription Use; Extension of Comment Period Proposed Rule Extension of Comment Period 2022-10-24T04:00:00Z 2022 10 2022-10-24T04:00:00Z   2022-11-22T18:58:05Z 2022-23033 0 0 090000648544cb97

Links from other tables